AR023975A1 - NEW GEN LAWSONIA SPP. AND ITS USES V - Google Patents
NEW GEN LAWSONIA SPP. AND ITS USES VInfo
- Publication number
- AR023975A1 AR023975A1 ARP000102294A ARP000102294A AR023975A1 AR 023975 A1 AR023975 A1 AR 023975A1 AR P000102294 A ARP000102294 A AR P000102294A AR P000102294 A ARP000102294 A AR P000102294A AR 023975 A1 AR023975 A1 AR 023975A1
- Authority
- AR
- Argentina
- Prior art keywords
- lawsonia
- lawsonia intracellularis
- prophylaxis
- treatment
- disease conditions
- Prior art date
Links
- 241001469654 Lawsonia <weevil> Species 0.000 title abstract 2
- 241001148567 Lawsonia intracellularis Species 0.000 abstract 3
- 241001465754 Metazoa Species 0.000 abstract 2
- 208000028774 intestinal disease Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 244000005700 microbiome Species 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 230000004727 humoral immunity Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Abstract
La presente se refiere en general a composiciones terapéuticas para el tratamiento y/o profilaxis de condiciones de enfermedad intestinal en animales ypájaros causadas o exacerbadas por Lawsonia intracellularis o similar, u otros microorganismos relacionados. En particular, suministra un gen nuevo derivado deLawsonia inracellularis que codifica un péptido, polipéptido o proteína SodC inmunogénico que es particularmente util como antígeno en una preparacion paravacuna para conferir inmunidad humoral contra Lawsonia intracellularis y patogenos relacionados en huéspedes animales. La presente también está orientada amétodos para el tratamiento y/o profilaxis de dichas condiciones de enfermedad intestinal y a agentes de diagnostico y procedimientos para detectar LawsoniaIntracellularis o similar, u otros microorganismos relacionados.This refers in general to therapeutic compositions for the treatment and / or prophylaxis of intestinal disease conditions in animals and birds caused or exacerbated by Lawsonia intracellularis or the like, or other related microorganisms. In particular, it supplies a new gene derived from Lawsonia inracellularis that encodes an immunogenic SodC peptide, polypeptide or protein that is particularly useful as an antigen in a paravaccine preparation for conferring humoral immunity against Lawsonia intracellularis and related pathogens in animal hosts. This is also aimed at methods for the treatment and / or prophylaxis of such intestinal disease conditions and at diagnostic agents and procedures for detecting Lawsonia Intracellularis or the like, or other related microorganisms.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13398999P | 1999-05-13 | 1999-05-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR023975A1 true AR023975A1 (en) | 2002-09-04 |
Family
ID=22461256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000102294A AR023975A1 (en) | 1999-05-13 | 2000-05-12 | NEW GEN LAWSONIA SPP. AND ITS USES V |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1177212A4 (en) |
| JP (1) | JP2003501013A (en) |
| AR (1) | AR023975A1 (en) |
| AU (1) | AU4385800A (en) |
| BR (1) | BR0011292A (en) |
| CA (1) | CA2372095A1 (en) |
| MX (1) | MXPA01011670A (en) |
| NZ (1) | NZ515332A (en) |
| PE (1) | PE20010238A1 (en) |
| WO (1) | WO2000069903A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6605696B1 (en) | 1999-10-22 | 2003-08-12 | Pfizer, Inc. | Lawsonia intracellularis proteins, and related methods and materials |
| ES2266090T3 (en) | 2000-12-20 | 2007-03-01 | Intervet International Bv | VACCINE AGAINST LAWSONIA INTRACELLULARIS. |
| EP1664100B1 (en) | 2003-09-12 | 2009-12-02 | Intervet International BV | Lawsonia intracellularis subunit vaccine |
| ATE470673T1 (en) * | 2004-01-22 | 2010-06-15 | Intervet Int Bv | VACCINES CONTAINING LAWSONIAINTRACELLULAR SUBUNIT |
| US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
| US8398994B2 (en) | 2005-07-15 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Lawsonia vaccine and methods of use thereof |
| EP2859900A1 (en) | 2006-12-11 | 2015-04-15 | Boehringer Ingelheim Vetmedica, Inc. | Effective method of treatment of porcine circovirus and lawsonia intracellularis infections |
| CN111830257B (en) * | 2020-07-17 | 2023-10-24 | 南京农业大学 | Pig-derived lawsonia intracellularis IPMA antigen detection method and application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5885823A (en) * | 1995-06-05 | 1999-03-23 | Nobl Laboratories, Inc. | Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
| DE69636228D1 (en) * | 1995-11-30 | 2006-07-20 | Agriculture Victoria Serv Pty | Therapeutic compositions for the treatment of Lawsonia intracellularis infections |
-
2000
- 2000-05-11 EP EP00924975A patent/EP1177212A4/en not_active Withdrawn
- 2000-05-11 WO PCT/AU2000/000436 patent/WO2000069903A1/en not_active Application Discontinuation
- 2000-05-11 BR BR0011292-5A patent/BR0011292A/en not_active IP Right Cessation
- 2000-05-11 CA CA002372095A patent/CA2372095A1/en not_active Abandoned
- 2000-05-11 AU AU43858/00A patent/AU4385800A/en not_active Abandoned
- 2000-05-11 NZ NZ515332A patent/NZ515332A/en unknown
- 2000-05-11 MX MXPA01011670A patent/MXPA01011670A/en unknown
- 2000-05-11 JP JP2000618319A patent/JP2003501013A/en active Pending
- 2000-05-12 PE PE2000000445A patent/PE20010238A1/en not_active Application Discontinuation
- 2000-05-12 AR ARP000102294A patent/AR023975A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PE20010238A1 (en) | 2001-03-03 |
| CA2372095A1 (en) | 2000-11-23 |
| AU4385800A (en) | 2000-12-05 |
| BR0011292A (en) | 2002-02-26 |
| EP1177212A4 (en) | 2002-08-28 |
| MXPA01011670A (en) | 2003-10-14 |
| EP1177212A1 (en) | 2002-02-06 |
| WO2000069903A1 (en) | 2000-11-23 |
| JP2003501013A (en) | 2003-01-14 |
| NZ515332A (en) | 2004-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2325737T3 (en) | VACCINE FOR PERIODONTAL DISEASE. | |
| TWI311057B (en) | C. perfringens alpha toxoid vaccine | |
| UA87665C2 (en) | Avirulent isolate of lawsonia intracellularis of european origin, vaccine for immunization of animals, use of avirulent isolate as vaccine, method for producing vaccine, method for culture of lawsonia intracellularis, method for diagnosing proliferative enteropathy in pigs, method for producing antiseurum to lawsonia intracellularis | |
| AU2006206577B2 (en) | Polypeptides for inducing a protective immune response against Staphylococcus aureus | |
| Droppa-Almeida et al. | Recombinant CP40 from Corynebacterium pseudotuberculosis confers protection in mice after challenge with a virulent strain | |
| BR9909483A (en) | Choline pneumococcal binding protein derivatives for vaccines | |
| BRPI0410795A (en) | infection treatment compositions for cattle and pigs | |
| UA103298C2 (en) | Method for the treatment of young piglets by means of pcv2 antigen | |
| BR0211049A (en) | Method of treatment or prevention of disease or dysfunction and use of mycoplasma hyopneumoniae | |
| AR023975A1 (en) | NEW GEN LAWSONIA SPP. AND ITS USES V | |
| BR0309570A (en) | Chimeric Camp Factors for Streptococcus Infection Vaccination | |
| MX2012003827A (en) | A cytolytic rtx-toxin from gallibacterium anatis. | |
| BRPI0419273A (en) | compositions and methods for treating microbial and parasitic infections in cattle and other animals | |
| Spithill et al. | Prospects for immunoprophylaxis against Fasciola hepatica (liver fluke) | |
| NZ515330A (en) | Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses | |
| BR0011294A (en) | Gene derived from lawsonia and related polypeptides, peptides and proteins and their uses | |
| JP2011103893A (en) | Recombinant haemophilus influenzae adhesin protein | |
| WO2005056601A3 (en) | Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse? | |
| BR0114835A (en) | Therapeutic compositions for treatment of lawsonia spp infection | |
| Vicente et al. | A Fasciola hepatica-derived fatty acid binding protein induces protection against schistosomiasis caused by Schistosoma bovis using the adjuvant adaptation (ADAD) vaccination system | |
| BR112022020438A2 (en) | COMPOSITIONS COMPRISING THREE OSPA FUSION PROTEINS FOR MEDICAL USE | |
| CA2929126C (en) | Outer membrane vesicles and uses thereof | |
| BRPI0414073A (en) | method for inducing an immune response against rotavirus infection from a rotavirus serotype, and use of an attenuated rotavirus strain of a serotype | |
| Figueiredo et al. | Whole-genome sequence of Francisella noatunensis subsp. orientalis strain FNO01 isolated from diseased Nile tilapia in Brazil | |
| US20090099083A1 (en) | Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis |